What treatment for a patient of PS 2-3 with stage IV non-small cell lung cancer?;Quel traitement pour un patient de PS-2/3 ayant un cancer bronchique non à petites cellules (CBNPC) de stade IV?

Revue des Maladies Respiratoires

Volumn 24, Issue 8 C2, 2007, Pages

  Moro Sibilot, D ^a   Pluquet, E ^a   Zalcman, G ^b   Brechot J M ^c   Souquet, P J ^d   Debieuvre, D ^e   Morin, F ^f   Morere J F ^c  

^a HÔPITAL MICHALLON   (France)

^b CHU CÔTE DE NACRE   (France)

^c AVICENNE HOSPITAL   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e Service de Pneumologie   (France)

^f Intergroupe Francophone de Cancérologie Thoracique   (France)

Author keywords

Chemotherapy; Lung cancer; Non small cell; Performance status 2 3; Stage IIIB; Stage IV

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ERLOTINIB; GEFITINIB; GEMCITABINE; IFOSFAMIDE; NAVELBINE; PACLITAXEL; PLACEBO; VINDESINE;

ANEMIA; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG MECHANISM; HUMAN; LUNG NON SMALL CELL CANCER; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PATIENT CARE; REVIEW; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 42649099934     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)